| DOV |
Report |
Adjusted operating EPS |
BEAT |
pred ~$2.75 vs. cons $2.72 |
MEDIUM |
| DOV |
Report |
Revenue |
IN-LINE |
pred ~$2.23B vs. cons $2.21B |
MEDIUM |
| DOV |
Report |
Organic growth |
BEAT |
pred ~5.60% vs. cons 5.27% |
MEDIUM |
| DOV |
Guide |
FY26 adjusted EPS |
UNCHANGED |
guide ~$10.55-$10.75 vs. cons $10.67 |
LOW |
| DOV |
Guide |
FY26 organic growth |
LOWER |
guide ~4%-6% vs. cons 5.45% |
LOW |
| DOV |
Guide |
Bookings / demand commentary (FY26) |
UNKNOWN |
sustained constructive tone; no numerical consensus |
LOW |
| DOV |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
LOW |
| DOV |
Return |
5-day cumulative residual |
+1.0% (STABILIZE) |
STABILIZE — mixed guide limits estimate follow-through |
LOW |